The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Belanoff Joseph K since 2016.
This trader's CIK number is 1286199.
At the time of last reporting, Belanoff Joseph K was the Chief Executive Officer of Corcept Therapeutics Inc. (stock ticker symbol CORT).
Also see all insider trading activities at Corcept Therapeutics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | CORT | 0 | $0 | 198,041 | $15,301,010 | 0 | $0 |
| 2022 | CORT | 0 | $0 | 335,019 | $8,799,002 | 800,000 | $1,664,000 |
| 2021 | CORT | 0 | $0 | 0 | $0 | 800,000 | $3,536,000 |
| 2019 | CORT | 0 | $0 | 0 | $0 | 782,885 | $931,633 |
| 2018 | CORT | 0 | $0 | 217,115 | $4,126,487 | 217,115 | $258,366 |
| 2016 | CORT | 0 | $0 | 1,000,000 | $8,627,500 | 1,000,000 | $1,500,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-02 | CORT | Sale | 40,000 | 70.76 | 2,830,560 |
| 2025-08-01 | CORT | Sale | 40,000 | 68.78 | 2,751,000 |
| 2025-07-17 | CORT | Sale | 615 | 73.69 | 45,317 |
| 2025-06-02 | CORT | Sale | 40,000 | 81.86 | 3,274,200 |
| 2025-05-02 | CORT | Sale | 40,000 | 72.87 | 2,914,840 |
| 2025-03-31 | CORT | Sale | 35,102 | 94.72 | 3,324,861 |
| 2025-04-01 | CORT | Sale | 350 | 114.71 | 40,148 |
| 2025-03-24 | CORT | Sale | 1,974 | 60.83 | 120,084 |
| 2022-07-06 | CORT | Option Ex | 800,000 | 2.08 | 1,664,000 |
| 2022-07-06 | CORT | Sale | 279,908 | 26.27 | 7,352,063 |
| 2022-07-07 | CORT | Sale | 55,111 | 26.25 | 1,446,939 |
| 2021-01-22 | CORT | Option Ex | 800,000 | 4.42 | 3,536,000 |
| 2019-03-20 | CORT | Option Ex | 782,885 | 1.19 | 931,633 |
| 2018-12-12 | CORT | Option Ex | 217,115 | 1.19 | 258,366 |
| 2018-12-12 | CORT | Sale | 217,115 | 19.01 | 4,126,487 |
| 2016-11-11 | CORT | Sale | 200,000 | 9.10 | 1,820,400 |
| 2016-11-10 | CORT | Sale | 300,000 | 8.90 | 2,670,600 |
| 2016-11-11 | CORT | Option Ex | 200,000 | 1.50 | 300,000 |
| 2016-11-10 | CORT | Option Ex | 300,000 | 1.50 | 450,000 |
| 2016-11-07 | CORT | Option Ex | 500,000 | 1.50 | 750,000 |
| 2016-11-07 | CORT | Sale | 500,000 | 8.27 | 4,136,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Belanoff Joseph K (Chief Executive Officer of Corcept Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.